Freeline Therapeutics(FRLN) - 2023 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form 40-F ☐ Voting Results of Annual General Meeting On June 28, 2023, Freeline Therapeutics Holdings plc ("Freeline" or the "Company") held its Annual General Meeting. The ordinary shares of ...